Welcome : Guest

HEMOGLOBIN A1C MONITORING - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 28 companies including many key and niche players such as -

A.Menarini Diagnostics Ltd.
Abbott Laboratories
ARKRAY, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Diazyme Laboratories, Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-1218
Price: $4950
Companies: 28
Pages: 265
Date: January 2018
Market Data Tables: 127
  Status: * New Report



TABLE OF CONTENTS


  HEMOGLOBIN A1C MONITORING (Complete Report) Pages : 265   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definition and Scope of Study.....I-3  
   HbA1c Devices: Critical Role in Monitoring & Management of Diabetes.....II-11$100
   Growth Stimulants in a Nutshell.....II-2
Major Concerns.....II-2
1$100
   While Developed Regions Lead, Asia-Pacific to Spearhead Long-term Growth.....II-3
Laboratory-based HbA1c Testing Devices Dominate HbA1c Market.....II-3
1$100
   POC-based HbA1c Monitoring Devices – The Faster Growing Category.....II-41$100
   Chromatography-based Hb Testing Devices Lead Market.....II-51$100
   Increasing Diabetes Prevalence and the Need for Diabetes Management to Prop-up Demand
  for HbA1c Monitoring Devices.....II-6
2$200
   Table 1: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes by Region for 2017 and 2045 (includes corresponding Graph/Chart).....II-81$350
   Table 2: Global Prevalence (%) of Diabetes in Adults (20-79) by Region for the Years 2017 and 2045 (includes corresponding Graph/Chart).....II-91$350
   Table 3: Global Prevalence of Diabetes - Number of Adults Diagnosed with Diabetes (in Million) by Gender for the Year 2017 (includes corresponding Graph/Chart).....II-10

Table 4: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender for the Year 2017 (includes corresponding Graph/Chart).....II-10
1$350
   Competitive Landscape.....II-11
Table 5: Leading Players in the Global HbA1c Reagents Market (2016): Percentage Breakdown of Revenues for Siemens and Others (includes corresponding Graph/Chart).....II-11
1$350
   Laboratory-based HbA1c Testing Products/ Analyzers of Select Players.....II-121$100
   Point-of-Care (POC) HbA1c Testing Products/ Analyzers of Select Players.....II-131$100
   High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices
  Market.....II-14
1$100
   Table 6: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-151$350
   Table 7: Elderly Population (65+ Years) as a % of Total Population (2000 & 2025) (includes corresponding Graph/Chart).....II-16
Increasing Obesity Levels Underpins Market Growth.....II-16
1$350
   Table 8: Global Obesity Epidemic: Percentage of Overweight, Obese and Severely Obese Adults for 2014 and 2025 (includes corresponding Graph/Chart).....II-17

Table 9: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart).....II-17
1$350
   Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices.....II-18 1$100
   Table 10: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart).....II-19

Table 11: Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart).....II-19
1$350
   Table 12: Healthcare Spending (in US$ Billion) by People with Diabetes (20-79 Years) for the Years 2011, 2013, 2015 and 2017 (includes corresponding Graph/Chart).....II-201$350
   Table 13: Health Spending due to Diabetes in Adults (20-79 years) - Breakdown by Region for the Years 2017 and 2045 (includes corresponding Graph/Chart).....II-211$350
   Table 14: Leading Countries by Health Expenditure on Diabetes by Adults for the Year 2017 (includes corresponding Graph/Chart).....II-221$350
   Table 15: Expenditure on Diabetes in Adult (20-79) as % of Total Healthcare Spending by Region (2017) (includes corresponding Graph/Chart).....II-231$350
   Table 16: Health Expenditure on Diabetes: Average Diabetes-Related Spending per Person with Diabetes in US$ by Region for 2017 (includes corresponding Graph/Chart).....II-241$350
   Table 17: Health Expenditure on Diabetes: Top Countries Ranked by Diabetes-Related Spending per Person with Diabetes (in US$) for 2017 (includes corresponding Graph/Chart).....II-251$350
   Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap.....II-26
Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?.....II-26
1$100
   Technology Developments Transform Diagnostics in Diabetes Care.....II-27
HbA1c Tests for Diabetes Diagnosis – Need to Address Issues Related to Hemoglobin
  Variants.....II-27
1$100
   Efforts Focus on Standardizing Reporting of HbA1c Results.....II-281$100
   Consistent and Precise Test Results Favor Growth in HbA1c Testing Devices
  Market.....II-29
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis.....II-29
Near Patient Testing Gaining Ground.....II-29
1$100
   Despite Reliability Issues, Prospects Remain Positive for POC Testing Market.....II-30
Advantages of POC HbA1c Tests over Lab Tests to Foster Adoption.....II-30
1$100
   Major Testing Methods in POC HbA1c Tests.....II-31
Immunoassays.....II-31
1$100
   Boronate Affinity Chromatography.....II-32
Micro-Optical Detection Methods.....II-32
Home HbA1c Testing: Lack of Reimbursement Coverage and Accuracy Concerns Affect
  Adoption.....II-32
2$200
   Regular HbA1c Test Keeps Heart Risk at Bay.....II-34
Glycated Albumin – A Potential Threat to HbA1c?.....II-34
1$100
   Higher Levels of Glycosylated Hemoglobin Increases Risk of Death.....II-35
Non-Invasive Glucose Meters and CBGM Devices Threaten HbA1c Market.....II-35
1$100
   ESC and ADA Release Revised Guidelines for HbA1c Testing.....II-361$100
   Study Finds Dentist Visits to be an Opportunity for HbA1c-based Diabetes Screening &
  Management.....II-37
1$100
   What Causes Diabetes?.....II-38
Types of Diabetes.....II-38
1$100
   Major Types of Diabetes.....II-39
Likely Complications.....II-39
Nephropathy (Kidney Disease).....II-39
Diabetic Neuropathy (Nerve Damage).....II-39
1$100
   Retinopathy (Damage to the Eye and Blindness).....II-40
Poor Healing of Infections and Wounds.....II-40
Impotence in Men.....II-40
Periodontal Disease.....II-40
Cardiovascular Disease.....II-40
Interpreting the A1c Range.....II-40
1$100
   Blood Glucose Level Guidelines in the US.....II-41
Key Diabetes Statistics.....II-41
Table 18: World Diabetes and Population Statistics (2017 & 2045) (includes corresponding Graph/Chart).....II-41

Table 19: Diabetes Prevalence in Rural and Urban Areas - Number of Adults with Diagnosed Diabetes (in Million) in Urban and Rural Areas for 2017 and 2045 (includes corresponding Graph/Chart).....II-41
1$350
   Table 20: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2017 and 2045 (includes corresponding Graph/Chart).....II-421$350
   Table 21: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2017 (includes corresponding Graph/Chart).....II-431$350
   Table 22: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region for the Year 2017 (includes corresponding Graph/Chart).....II-441$350
   Therapeutic Options for Diabetes.....II-45
Oral Medications for Type 2 Diabetes.....II-45
Side Effects of Insulin Therapy.....II-45
1$100
   Maintaining A1c Test Result Below 7%.....II-46
Common Diabetes Management Practices.....II-46
1$100
   Hemoglobin – A Brief.....II-47
Hemoglobin A1c – Description.....II-47
HbA1c Monitoring.....II-47
What is A1c?.....II-47
1$100
   1. HbA1c Laboratory Testing.....II-48
2. HbA1c Point of Care Testing & Self-Monitoring.....II-48
Hemoglobin A1c (HbA1c) Test.....II-48
Interpreting HbA1c Test Readings.....II-48
1$100
   Interpreting HbA1c Test Readings.....II-49
Result of Hemoglobin A1c Test.....II-49
Clinical Use of A1c Testing.....II-49
Advantages of A1c Assessment & Interpretation.....II-49
1$100
   Risks Associated with HbA1c Testing.....II-50
Methods of Measurement for Glycohemoglobin.....II-50
Why Opt for HbA1c Testing?.....II-50
1$100
   The Diabetes Control & Complications Trial (DCCT).....II-51
The Kumamoto and UK Prospective Studies.....II-51
Glycemia Tests Used in Monitoring Diabetes.....II-51
Urine Glucose Testing.....II-51
1$100
   Glycated Protein Testing.....II-52
Table 23: Relation Between A1c Level and Mean Plasma Glucose Levels.....II-52
HbA1c Test Types.....II-52
HbA1c Laboratory Testing.....II-52
1$350
   Analytical Techniques Used for Quantifying HbA1c in Labs.....II-53
Standardization of HbA1c Results.....II-53
1$350
   Table 24: CAP Accuracy Grading for HbA1c Measurements (2007-2013).....II-54
HbA1c Point of Care Testing & Self-Monitoring.....II-54
1$350
   Standardization of Glycated Hemoglobin Testing.....II-55
NGSP Standardization of HbA1c.....II-55
IFCC Standardization of HbA1c.....II-55
1$100
   HbA1c Reporting.....II-56
Table 25: A1c (%) and Corresponding eAG Number (in mg/dl or mmol/l).....II-56
1$350
   ARKRAY Introduces ADAMS™ A1c HA-8180V System for HbA1c Testing.....II-57
HemoCue Unveils HemoCue HbA1c 501 System in Thailand.....II-57
Diazyme Gains FDA 510(k) Clearance Direct HbA1c Assay.....II-57
IDG/Sanzay Unveils VERI-Q MULTI Monitoring System.....II-57
ARKRAY Launches ADAMS A1c Lite HA-8380V in Japan.....II-57
Biorex Unveils HbA1c Micro-Column Kit.....II-57
MedTest Launches Reagents for Mindray™ BS-480 Chemistry Analyzer in US.....II-57
1$100
   ARKRAY Unveils New Instruments for HbA1c Measurement.....II-58
Roche Introduces New Cobas C513 Analyser.....II-58
ARKRAY Launches B-analyst HbA1c Control for HbA1c Tests.....II-58
ARKRAY Unveils CinQ HbA1c Range of Reagent Kit.....II-58
Transasia Bio-Medicals Introduces HbA1c & HbA2/F-Fully Automated Analyzer.....II-58
ARKRAY Releases PocketChem A1c HbA1c Analyzer.....II-58
1$100
   Abbott Takes Over Alere.....II-59
Siemens Healthcare Rebrands as Siemens Healthineers.....II-59
Sinocare Takes Over PTS Diagnostics.....II-59
Biosurfit Gains CE Mark for HbA1c Test.....II-59
Bio-Rad Bags FDA Approval for D-100™ System for A1c Testing.....II-59
Bio-Rad’s VARIANT™ II TURBO HbA1c Kit – 2.0 Receives FDA Approval for Use in
  Diabetes Diagnosis.....II-59
1$100
   Abnova Concludes Clinical Trial for Personal A1c Diabetes Rapid Test.....II-60
Ortho-Clinical Diagnostics Obtains FDA Approval for VITROSฎ Chemistry Products HbA1c
  Reagent Kit.....II-60
1$100
   A.Menarini Diagnostics Ltd. (UK).....II-61
Abbott Laboratories (USA).....II-61
Alere, Inc. (USA).....II-61
1$100
   ARKRAY, Inc. (Japan).....II-62
Beckman Coulter, Inc. (USA).....II-62
1$100
   Bio-Rad Laboratories, Inc. (USA).....II-63
Diazyme Laboratories, Inc. (USA).....II-63
1$100
   EKF Diagnostics Holdings Plc (UK).....II-64
HemoCueฎ AB (Sweden).....II-64
OSANG Healthcare Co., Ltd (South Korea).....II-64
1$100
   PTS Diagnostics (USA).....II-65
Roche Diagnostics (Switzerland).....II-65
1$100
   Siemens Healthineers (Germany).....II-66
Tosoh Bioscience, Inc. (USA).....II-66
1$100
   Trinity Biotech plc (Ireland).....II-671$100
   Table 26: World Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-681$350
   Table 27: World Historic Review for HbA1c Monitoring Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-691$350
   Table 28: World 14-Year Perspective for HbA1c Monitoring Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-701$350
   Table 29: World Recent Past, Current & Future Analysis for Laboratory-based HbA1c Testing Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-711$350
   Table 30: World Historic Review for Laboratory-based HbA1c Testing Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-721$350
   Table 31: World 14-Year Perspective for Laboratory-based HbA1c Testing Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-731$350
   Table 32: World Recent Past, Current & Future Analysis for Point-of-Care (POC)-based HbA1c Testing Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-741$350
   Table 33: World Historic Review for Point-of-Care (POC)-based HbA1c Testing Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-751$350
   Table 34: World 14-Year Perspective for Point-of-Care (POC)-based HbA1c Testing Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-761$350
   A. Market Analysis.....III-1
The United States – The Largest Market for HbA1c Monitoring.....III-1
1$75
   Table 35: Diabetes and Population Statistics in North America and Caribbean Region (2017 & 2045) (includes corresponding Graph/Chart).....III-2

Table 36: Diabetes Statistics in the US (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s).....III-2
Aging Population: A Weighty Growth Factor.....III-2
1$200
   Table 37: Diabetes Prevalence in the US (2015): Percentage Breakdown of Number of Diabetics by Gender (includes corresponding Graph/Chart).....III-3

Table 38: Diabetes Prevalence in the US (2015): Percentage Breakdown of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-3

Table 39: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-3
1$200
   Prevalence Varies by Race/Ethnicity.....III-4
Table 40: Diabetes Prevalence Rate (%) in the US - Breakdown by Ethnicity/Race for the Year 2020 (includes corresponding Graph/Chart).....III-4
Economic Burden of Diabetes.....III-4
1$200
   Table 41: Total Healthcare Expenditure in US$ Billion) and Average Healthcare Expenditure Per Person (in US$) on Diabetes among Adults (20-79) for 2017.....III-5
HbA1c – Increasingly Moving into Physician’s Office.....III-5
HbA1c Testing for Diabetes Detection Gains Support.....III-5
1$200
   ADA 2015 Diabetes Diagnostic Criteria.....III-6
Growing Inclination towards CLIA- Waived Tests.....III-6
Need for Further Stringency in Requirements Arises.....III-6
1$75
   Healthcare Reform Legislation: Impact on Diabetes Diagnostics.....III-71$75
   Competition.....III-8
Table 42: Leading Players in the US Near Patient HbA1c Testing Market (2015): Percentage Breakdown of Revenues for Alere, Siemens and Others (includes corresponding Graph/Chart).....III-8
Product Launches.....III-8
1$200
   Strategic Corporate Developments.....III-91$75
   Key Players.....III-103$225
   B. Market Analytics.....III-13
Table 43: US Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-13
1$200
   Table 44: US Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-141$200
   Table 45: US 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-151$200
   A. Market Analysis.....III-16
Rising Diabetes Cases in Canada – An Opportunity for HbA1c Monitoring
  Market.....III-16
Table 46: Diabetes Statistics in Canada (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s).....III-16

Table 47: Adult Diabetes in Canada (2017E): Percentage Share Breakdown of Diabetic Population by Gender(includes corresponding Graph/Chart).....III-16
1$200
   Table 48: Adult Diabetes in Canada (2017E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart).....III-17
B. Market Analytics.....III-17
Table 49: Canadian Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-17
1$200
   Table 50: Canadian Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-181$200
   Table 51: Canadian 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-191$200
   A. Market Analysis.....III-20
High Susceptibility of the Elderly to Diabetes Sustains Market Growth.....III-20
Table 52: Diabetes Statistics in Japan (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s).....III-20
Product Launches.....III-20
1$200
   ARKRAY, Inc. – A Major Player.....III-211$75
   B. Market Analytics.....III-22
Table 53: Japanese Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-22
1$200
   Table 54: Japanese Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-231$200
   Table 55: Japanese 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-241$200
   A. Market Analysis.....III-25
Healthy Growth Forecast for HbA1c Monitoring Market in Europe.....III-25
1$75
   Diabetes Statistics in Europe.....III-26
Table 56: Diabetes and Population Statistics in Europe (2017 & 2045) (includes corresponding Graph/Chart).....III-26
1$200
   Table 57: Diabetes Statistics in Europe (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-27
Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption.....III-27
1$200
   B. Market Analytics.....III-28
Table 58: European Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-28
1$200
   Table 59: European Historic Review for HbA1c Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-291$200
   Table 60: European 14-Year Perspective for HbA1c Monitoring Devices by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-301$200
   Table 61: European Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-311$200
   Table 62: European Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-321$200
   Table 63: European 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Current and Future Analysis.....III-34
Table 64: Diabetes Statistics in France (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s).....III-34
1$200
   B. Market Analytics.....III-35
Table 65: French Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-35
1$200
   Table 66: French Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-361$200
   Table 67: French 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-371$200
   A. Market Analysis.....III-38
Market Overview.....III-38
Table 68: Diabetes Statistics in Germany (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s).....III-38
Strategic Corporate Development.....III-38
Siemens Healthineers – A Key Player.....III-38
1$200
   B. Market Analytics.....III-39
Table 69: German Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-39
1$200
   Table 70: German Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-401$200
   Table 71: German 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-411$200
   A. Market Analysis.....III-42
Current and Future Analysis.....III-42
Table 72: Diabetes Statistics in Italy (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s).....III-42
1$200
   B. Market Analytics.....III-43
Table 73: Italian Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-43
1$200
   Table 74: Italian Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-441$200
   Table 75: Italian 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-451$200
   A. Market Analysis.....III-46
Market Overview.....III-46
Table 76: Diabetes Statistics in the UK (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s).....III-46
Rising Obesity Cases – Increased Risk of Diabetes.....III-46
1$200
   Type 1 Diabetes in Children.....III-47
Table 77: Number of Children with Type 1 Diabetes in Select Countries (2017) (includes corresponding Graph/Chart).....III-47
NHS England Launches Action for Diabetes Plan.....III-47
1$200
   Product Launch.....III-48
Key Players.....III-48
1$75
   B. Market Analytics.....III-49
Table 78: UK Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-49
1$200
   Table 79: UK Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-501$200
   Table 80: UK 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-511$200
   A. Market Analysis.....III-52
Increasing Diabetes Cases – Potential for HbA1c Monitoring Market.....III-52
Table 81: Diabetes Statistics in Spain (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s).....III-52
1$200
   B. Market Analytics.....III-53
Table 82: Spanish Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-53
1$200
   Table 83: Spanish Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-541$200
   Table 84: Spanish 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-551$200
   A. Market Analysis.....III-56
Rising Diabetes Prevalence Presents Opportunity for HbA1c Monitoring
  Market.....III-56
Table 85: Diabetes Statistics in Russia (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s).....III-56
1$200
   B. Market Analytics.....III-57
Table 86: Russian Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-57
1$200
   Table 87: Russian Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-581$200
   Table 88: Russian 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-591$200
   A. Market Analysis.....III-60
Current and Future Analysis.....III-60
Strategic Corporate Developments.....III-60
Key Players.....III-60
2$150
   B. Market Analytics.....III-62
Table 89: Rest of Europe Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-62
1$200
   Table 90: Rest of Europe Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-631$200
   Table 91: Rest of Europe 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-641$200
   A. Market Analysis.....III-65
High Risk Population and Underpenetrated Market Offers Huge Growth
  Opportunities.....III-65
1$75
   Table 92: Diabetes and Population Statistics in Western Pacific (2017 & 2045) (includes corresponding Graph/Chart).....III-661$200
   Table 93: Diabetes Statistics in Western Pacific (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-671$200
   Table 94: Diabetes and Population Statistics in South East Asia (2017 & 2045) (includes corresponding Graph/Chart).....III-681$200
   Table 95: Diabetes Statistics in South East Asia (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-691$200
   B. Market Analytics.....III-70
Table 96: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-70
1$200
   Table 97: Asia-Pacific Historic Review for HbA1c Monitoring Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-711$200
   Table 98: Asia-Pacific 14-Year Perspective for HbA1c Monitoring Devices by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-721$200
   Table 99: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-731$200
   Table 100: Asia-Pacific Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-741$200
   Table 101: Asia-Pacific 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-751$200
   A. Market Analysis.....III-76
Current and Future Analysis.....III-76
A Market with Huge Untapped Potential for HbA1c Monitoring Devices.....III-76
1$75
   Table 102: Diabetes Statistics in China (2017) - Number of Adults with Diabetes (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (in ‘000s), and Number of Diabetes-Related Deaths (in ‘000s).....III-77
B. Market Analytics.....III-77
Table 103: Chinese Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-77
1$200
   Table 104: Chinese Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-781$200
   Table 105: Chinese 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-791$200
   A. Market Analysis.....III-80
Current and Future Analysis.....III-80
HbA1c Testing on Growth Spree.....III-80
1$75
   Table 106: Diabetes Statistics in India (2017) - Number of Adults with Diabetes (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (in ‘000s), and Number of Diabetes-Related Deaths (in ‘000s).....III-81
Growth Stimulants & Challenges in a Nutshell.....III-81
Product Launch.....III-81
1$200
   B. Market Analytics.....III-82
Table 107: Indian Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-82
1$200
   Table 108: Indian Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-831$200
   Table 109: Indian 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-841$200
   A. Market Analysis.....III-85
Current and Future Analysis.....III-85
Australia: Rising Diabetes Prevalence Presents Opportunity for HbA1c Testing
  Market.....III-85
1$75
   Table 110: Diabetes Population in Australia (2017): Percentage Breakdown of Number of Individuals with Diabetes by Age Group (includes corresponding Graph/Chart).....III-86
Strategic Corporate Developments.....III-86
OSANG Healthcare Co., Ltd (South Korea) – A Major Player.....III-86
1$200
   B. Market Analytics.....III-87
Table 111: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-87
1$200
   Table 112: Rest of Asia-Pacific Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-881$200
   Table 113: Rest of Asia-Pacific 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-891$200
   A. Market Analysis.....III-90
Current and Future Analysis.....III-90
Diabetes in Latin America – A Glance at Key Statistics.....III-90
1$75
   Table 114: Diabetes and Population Statistics in South & Central America (2017 & 2045) (includes corresponding Graph/Chart).....III-911$200
   Table 115: Diabetes Statistics in South & Central America (2017) - Number of Adults with Diabetes (20-79 (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-921$200
   Key Opportunity Indicator: Aging Population.....III-93
Table 116: Aging Population in Latin America and the Caribbean by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-93
1$200
   Table 117: Aging Population in Latin America (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population by Country (includes corresponding Graph/Chart).....III-941$200
   B. Market Analytics.....III-95
Table 118: Latin American Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-95
1$200
   Table 119: Latin American Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-961$200
   Table 120: Latin American 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-971$200
   A. Market Analysis.....III-98
Current and Future Analysis.....III-98
Diabetes Statistics in Africa and the Middle East.....III-98
Table 121: African Diabetes and Population Statistics (2017 & 2045) (includes corresponding Graph/Chart).....III-98
1$200
   Table 122: Diabetes Statistics in Africa (2017) - Number of Adults (20-79) with Diabetes (in ‘000s), Diabetes National Prevalence (%), Adults with Undiagnosed diabetes (20-79) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-991$200
   Table 123: Diabetes and Population Statistics in Middle East and North Africa for 2017 and 2045 (includes corresponding Graph/Chart).....III-1001$200
   Table 124: Diabetes Statistics in Middle East and North Africa (2017) - Number of Adults with Diabetes (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed diabetes (20-79) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1011$200
   B. Market Analytics.....III-102
Table 125: Rest of World Recent Past, Current & Future Analysis for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-102
1$200
   Table 126: Rest of World Historic Review for HbA1c Monitoring Devices by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1031$200
   Table 127: Rest of World 14-Year Perspective for HbA1c Monitoring Devices by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1041$200
  
Total Companies Profiled: 28 (including Divisions/Subsidiaries - 38)

Region/Country Players

The United States 18 Japan 2 Europe 15 Germany 3 The United Kingdom 5 Italy 1 Rest of Europe 6 Asia-Pacific (Excluding Japan) 3
Click here to request a full table of contents and more details on this project.